1 recruiting. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Recruiting 1 |
Follow Neurotech Pharmaceuticals: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 4 Study: Long-term Safety and Efficacy of NT-501 in MacTel Type 2, Including Sham Procedure Participants NT-501/revakinagene taroretcel-lwey - Macular Telangiectasia Type 2 (MacTel) | Phase 4 | Recruiting | Neurotech Pharmaceuticals | 234 | 2025-11-21 | 2026-09-25 |
Australia (1) · United States (1)